CBD
CBD testing
Eurofins Food & Feed Testing laboratories offer cannabinoid analysis and regulatory consultancy aligned to current regulation for hemp seed products, CBD novel foods and supplements.
Key services
In addition to the analysis of Δ9-THC, Δ9-THC acid and its sum as well as CBD, our service offering includes the analysis of a wide range of other cannabinoids:
- Δ9-Tetrahydrocannabinol (Δ9-THC)
- Δ9-Tetrahydrocannabinolic acid (Δ9-THCA)
- Δ8-Tetrahydrocannabinol (Δ8-THC)
- Sum Δ9-Tetrahydrocannabinol
- Cannabidiol (CBD)
- Cannabichromene (CBC)
- Cannabidiolic acid (CBDA)
- Cannabidivarin (CBDV)
- Cannabidivarinic acid (CBDVA)
- Cannabigerol (CBG)
- Cannabigerolic acid (CBG-A)
- Cannabinol (CBN)
- Tetrahydrocannabivarin (THCV)
Additional services
- Heavy metals
- Pesticide residues
- Mycotoxins
- Pathogen detection and traceability
- Residual solvents, per batch or stability study design
- Optional label claim verification and serving size checks
Key product categories
Eurofins Food & Feed Testing currently offers analyses for hemp-containing foodstuffs, including:
- Oils and tinctures
- Softgels and capsules
- Gummies and confectionery
- Beverages and syrups
- Bakery and cereals
- Bars and snacks
- Hemp seed oils
- Hemp seed flours and proteins
An analysis of cannabis plants, flowers, resin or other plant parts is currently under preparation.
Why test CBD and THC in food and supplements?
- Compliance for hemp seed matrices: Since 2023, maximum levels for Δ9-THC in hemp seeds and products derived from them have been in force, as specified in the Contaminants Regulation (EU) 2023/915
- EFSA published a draft scientific opinion on the derivation of a health-based guidance value for Δ8-THC and its presence in food in 2025
- Toxicological evaluation of THC: In its opinion published in January 2020, the European Food Safety Authority (EFSA) set an acute reference dose (ARfD) of 1 µg/kg body weight. This value can already be exceeded when consuming small amounts of a food containing THC. However, the EFSA points to a lack of analytical and consumption data, which would be necessary for a better assessment.
- Market access: CBD remains a novel food requiring authorisation; robust testing supports submissions and responsible reformulation
Get in touch
Would you like to find out more about our testing solutions, or do you need analytical support? Contact us today to find out more about our testing and consultancy services.